Strumento inattivo

Azioni Power3 Medical Products, Inc.

Azioni

Prezzo di chiusura OTC Bulletin Board Altri mercati azionari
- ^USD	-

Power3 Medical Products, Inc. : Amarantus BioSciences Licenses Parkinson's Disease Diagnostic Biomarker Test from Power3 Medical Products	23/01/12
POWER 3 MED PROD : Power3 Medical to Publish Medical Breakthrough Documented During Clinical Trials of Power3 Medical's Flag Ship NuroPro® Diagnostic	20/05/10
POWER 3 MED PROD : Power3 Medical Announces Filing of Two Provisional Patent Applications with the USPTO	14/05/10
POWER 3 MED PROD : Power3 Presents State of the Company Report at the Economic Development Partners Luncheon	12/05/10
POWER 3 MED PROD : Power3's Dr. Ira L. Goldknopf Stated in an Interview That the Company Plans to Completely and Strategically Reposition Itself Through a Consolidation of Stem Cell, Diagnostic, and Therapeutic Companies and Intellectual Property	07/05/10

Dirigenti	Titolo	Età	Da
Helen R. Park CEO	Chief Executive Officer	87	07/09/08
Ira L. Goldknopf CHM	Chairman	76	01/05/04

Amministratori	Titolo	Età	Da
Ira L. Goldknopf CHM	Chairman	76	01/05/04
Helen R. Park CEO	Chief Executive Officer	87	07/09/08

Settore

	Variaz. 1 gen.	Capi.
MODERNA, INC.	+26,37%	48,16 Mrd
IQVIA HOLDINGS INC.	-1,01%	41,73 Mrd
LONZA GROUP AG	+45,09%	41,03 Mrd
CELLTRION, INC.	-5,31%	28,77 Mrd
ICON PUBLIC LIMITED COMPANY	+9,34%	25,59 Mrd
ALNYLAM PHARMACEUTICALS, INC.	-21,69%	18,96 Mrd
BIO-TECHNE CORPORATION	+6,23%	12,92 Mrd
MEDPACE HOLDINGS, INC.	+26,99%	12,03 Mrd
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3,38%	11,77 Mrd